New DHVI T32 Program Will Train Scientists in Vaccine and Biologics Development
The Duke Human Vaccine Institute (DHVI) has received a new T32 training award to establish the Vaccines and Biologics Against Infectious Diseases (VBAID) program, an interdisciplinary initiative that prepares postdoctoral scientists to develop vaccines and antibody-based countermeasures against emerging and re-emerging infectious diseases.
New experimental approach could help immune system attack both viral infection and cancer
In study results reported in Science Translational Medicine, researchers demonstrated that the engineered antibody can target cancer cells and virus-infected cells that use a molecule called HLA-E to hide from immune attack. The research team was led by Mihai Azoitei, PhD, Barton F. Haynes MD, and Joyce Hwang, MD, PhD.
Experimental vaccine strategy clears major hurdle in HIV prevention
For decades, scientists have chased a daunting HIV vaccine goal: teaching the immune system to make rare antibodies capable of stopping the HIV virus’s many forms.
Leadership Transition at the Duke Human Vaccine Institute
After nearly four decades, Barton Haynes, MD, has decided to step down as director of the Duke Human Vaccine Institute (DHVI).
Wilton Williams receives faculty research prize
Wilton Williams, PhD, an associate professor in surgery and DHVI member, has been named a recipient of the Ruth and A. Morris Williams Faculty Research Prize.
Locking Viruses Out: A New Approach to Infection Prevention
Nicholas Heaton, PhD, professor of molecular genetics and microbiology, is looking at host-targeted treatments for viral infections.
Nicholas Heaton Awarded Distinguished Professorship
Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.
The DNA repair duo cancers use to build ecDNA — and gain an advantage
Duke University School of Medicine researchers, led by DHVI affiliate Zhao Zhang, PhD, have discovered the keys to survival for a circular form of DNA that drives many aggressive cancers.
Institute Director Bart Haynes honored for 45 years of Duke service
On March 9, members of the Duke Human Vaccine Institute (DHVI) gathered virtually for the annual DHVI Service & Core Values Awards Ceremony to celebrate
Avoiding Viral Illness During the Holidays
Two Duke Health physicians, including DHVI affiliate Cameron Wolfe, MBBS, share advice to help people weather the spikes in disease during the winter.